BusinessCapricor Announces Initiation of HOPE-2 Clinical Trial of CAP-1002 for Duchenne Muscular DystrophyBy Nasdaq OMXApr 30, 2018, 11:01 AM UTC
BusinessAmerican CryoStem to Exhibit at The Aesthetic Meeting 2018 in New York, NYBy Nasdaq OMXApr 26, 2018, 12:01 PM UTC
BusinessCapricor to Provide Presentation at the Alliance for Regenerative Medicine’s Investor DayBy Nasdaq OMXApr 12, 2018, 11:00 AM UTC
BusinessAmerican CryoStem Enters Into Agreement to License its Patented Adipose Tissue and Stem Cell Technologies in ThailandBy Nasdaq OMXApr 5, 2018, 10:00 AM UTC
BusinessThe Alliance for Regenerative Medicine Releases Complete Agenda for Sixth Annual Cell & Gene Therapy Investor DayBy Nasdaq OMXMar 28, 2018, 2:47 PM UTC
BusinessBioStem Technologies Inc. Announces Engagement of Dr. Felix Amon for Pharmaceutical Business DevelopmentBy Nasdaq OMXMar 13, 2018, 10:16 PM UTC
BusinessBioStem Technologies Inc. Enter into Agreement with Barbara Krutchkoff, PhD. To Guide Scientific AffairsBy Nasdaq OMXMar 9, 2018, 10:09 PM UTC
BusinessThe Alliance for Regenerative Medicine Releases 2017 Annual Data Report, Highlighting Sector Trends and MetricsBy Nasdaq OMXMar 5, 2018, 3:42 PM UTC
